Astera Labs (NASDAQ:ALAB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Astera Labs (NASDAQ:ALAB) from a hold rating to a buy rating in a report released on Monday morning.

Several other research firms have also issued reports on ALAB. Needham & Company LLC increased their price target on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research report on Friday, August 29th. Barclays reiterated an “equal weight” rating and set a $155.00 price target on shares of Astera Labs in a research report on Monday, October 20th. CICC Research initiated coverage on shares of Astera Labs in a research report on Friday, August 29th. They set an “outperform” rating and a $190.00 price target on the stock. Finally, Cowen initiated coverage on shares of Astera Labs in a research report on Tuesday, September 30th. They set a “hold” rating on the stock. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $181.59.

Astera Labs Stock Up 1.5%

Shares of Astera Labs stock opened at $181.94 on Monday. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a 50-day simple moving average of $196.85 and a two-hundred day simple moving average of $139.01. The stock has a market capitalization of $30.24 billion, a price-to-earnings ratio of 163.91, a price-to-earnings-growth ratio of 4.40 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 14.21%. The business had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the previous year, the company earned $0.23 EPS. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 91,441 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the transaction, the chief operating officer directly owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the transaction, the chief executive officer owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 534,480 shares of company stock worth $97,000,380 over the last 90 days. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the stock. Plato Investment Management Ltd bought a new stake in Astera Labs during the 3rd quarter worth approximately $169,000. Alps Advisors Inc. bought a new stake in Astera Labs during the 3rd quarter worth approximately $390,000. SlateStone Wealth LLC grew its holdings in Astera Labs by 1.3% during the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock worth $2,495,000 after acquiring an additional 160 shares during the last quarter. Capital Investment Advisory Services LLC bought a new stake in Astera Labs during the 3rd quarter worth approximately $1,287,000. Finally, HighPoint Advisor Group LLC bought a new stake in Astera Labs during the 3rd quarter worth approximately $217,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.